Akeso enrolls first patient in global Phase III cadonilimab trial
The trial will test cadonilimab with chemotherapy against chemotherapy with or without nivolumab in first-line HER2-negative advanced gastric or GEJ cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.